Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study. - Wikidata - awgldk - TriplyDB

Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study.

Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study.

http://www.wikidata.org/entity/Q43166491

about

Immunotherapy for cancer in the central nervous system: Current and future directions Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines Immunotherapy advances for glioblastoma An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma Monitoring of regulatory T cell frequencies and expression of CTLA-4 on T cells, before and after DC vaccination, can predict survival in GBM patients Prognostic value of residual fluorescent tissue in glioblastoma patients after gross total resection in 5-aminolevulinic Acid-guided surgery.DCVax®-L--developed by Northwest Biotherapeutics A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients.Cytokine responsiveness of CD8(+) T cells is a reproducible biomarker for the clinical efficacy of dendritic cell vaccination in glioblastoma patients.Immunotherapy of malignant gliomas using autologous and allogeneic tissue cells.Overview of cellular immunotherapy for patients with glioblastoma.Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial.Stratification according to HGG-IMMUNO RPA model predicts outcome in a large group of patients with relapsed malignant glioma treated by adjuvant postoperative dendritic cell vaccination.α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial.Dendritic cell-based vaccines: barriers and opportunities Immune modulation effects of concomitant temozolomide and radiation therapy on peripheral blood mononuclear cells in patients with glioblastoma multiforme.Personalized medicine for gliomas The future of high-grade glioma: Where we are and where are we going.Victory and defeat in the induction of a therapeutic response through vaccine therapy for human and canine brain tumors: a review of the state of the art.Cellular-based immunotherapies for patients with glioblastoma multiforme.Trial watch: Dendritic cell-based interventions for cancer therapy Dendritic cell vaccination in glioblastoma after fluorescence-guided resection Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma.Irradiation of necrotic cancer cells, employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade glioma.Immunotherapy in glioblastoma: emerging options in precision medicine Prioritization schema for immunotherapy clinical trials in glioblastoma.Immune response in patients with newly diagnosed glioblastoma multiforme treated with intranodal autologous tumor lysate-dendritic cell vaccination after radiation chemotherapy.Immune-checkpoint blockade and active immunotherapy for glioma.Classifying Glioblastoma Multiforme Follow-Up Progressive vs. Responsive Forms Using Multi-Parametric MRI Features.Temozolomide does not impair gene therapy-mediated antitumor immunity in syngeneic brain tumor models.Advances in Immunotherapy for Glioblastoma Multiforme.Experimental immunotherapy for malignant glioma: lessons from two decades of research in the GL261 model.Galectin-1 and immunotherapy for brain cancer.Highlights of the second international conference on "Immunotherapy in Pediatric Oncology".Immunotherapy for the treatment of glioblastoma.Cellular immunotherapy for soft tissue sarcomas.Achieving graft-versus-tumor effect in brain tumor patients: from autologous progenitor cell transplant to active immunotherapy.Clinical trials in cellular immunotherapy for brain/CNS tumors.Dendritic cell vaccination in pediatric gliomas: lessons learnt and future perspectives.Glioblastoma multiforme: State of the art and future therapeutics.

P2860

Q26750765-CAEDFA30-800C-4AE2-8C28-408FAC4231B0 Q26772715-A230FA76-942B-4418-9D16-9E49F21DE587 Q26866513-A60B417C-8401-48CD-95C5-BD6D06363870 Q27024830-A28BE336-4266-42E7-8EF1-3D736F0AAA78 Q28730798-54D2981A-8D5B-4092-9C09-19E18AB8BA30 Q30628099-92CF7189-DFCB-42EB-BDF0-68ECFA8C6637 Q30875456-C8048609-0F50-49A2-B533-D6740D2EF600 Q33668084-D589E339-1602-4F04-B6A1-E4BEC773BEC4 Q33691858-3E021910-9851-4F80-8505-DB7432D8D5F5 Q34140756-30AA9CD6-7219-4702-9D71-AA4437764416 Q34189694-B6A6CB66-7894-4D2A-89A6-74F6912309A4 Q34242939-3E0E0602-FD56-4C59-9F78-9E3CC9FF8FF4 Q34260758-3B9136D5-1496-44FC-9109-63E1DF6E1D7C Q34523918-264F796B-6912-4CE5-BE60-5649215606CB Q34661797-D89E4EFB-58E4-49C0-8FA1-2D43C639B219 Q34722857-E4F2A1B4-1BE1-4CCA-84DB-D7F681D0C23E Q35114080-B6E9767A-DA74-49E3-AB3E-3333179B6D7B Q35114090-E00AC2FB-F88A-4363-A744-48B1D06E8EF7 Q35799695-3AFE51C7-8D80-4B12-AD05-C542A90654FF Q35821404-D5DDF807-13B9-4788-94EC-63FD06958122 Q36388529-1E02B296-4DF7-4D36-846C-60FD52CB26BF Q36507978-C3896050-7F85-4BC2-AD4D-70EDEB8207B5 Q36523499-43E3EA71-57A8-4BF7-BD9C-1A83C1B6D332 Q36710917-01312B7A-FDFB-4274-9D78-98B33D126C30 Q37050960-B96733F2-4143-4153-85C1-DC1E74861E2A Q37078999-D61FB941-96D0-424D-B919-E78C5811F3C0 Q37154132-7738A6CC-8011-4E3D-8531-E1D7CDD0B79A Q37420586-2ADB3A78-B4EB-4844-9690-4252266E2A13 Q37578230-9E975EA3-F5AA-41F3-9A02-BEB8C124F442 Q37647868-79F1B165-D394-4E21-91C3-CF46B06AF096 Q37680966-4265FCE7-EF0B-40B1-9432-B66B98166F81 Q37814208-39C2BCAF-A0B7-4258-B774-7DBB6C356EB2 Q37862237-53CACAA7-2B64-4AC6-8E2B-2318D01997DD Q37919880-ADEF8535-214D-49C1-BFE4-C6D38FD57456 Q37980026-CD680114-1CE8-4129-8499-35FAAF4F6038 Q37991779-50FB0C0F-8A72-48AB-AF57-AFFCB7B5C95E Q38063583-03B89895-263C-44A6-9EB8-818B06C5C112 Q38094811-6F6090BA-B51F-4A4E-94D4-1B3782469E78 Q38176625-58605260-1A63-4A9E-A6CC-48F1090C7978 Q38225874-C803EA45-98CE-49E5-B534-D38289C6D065

P2860

Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study.

http://www.wikidata.org/entity/Q43166491

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Integration of autologous dend ...... oma multiforme: a pilot study.

@en

Integration of autologous dend ...... oma multiforme: a pilot study.

@nl

type

label

Integration of autologous dend ...... oma multiforme: a pilot study.

@en

Integration of autologous dend ...... oma multiforme: a pilot study.

@nl

prefLabel

Integration of autologous dend ...... oma multiforme: a pilot study.

@en

Integration of autologous dend ...... oma multiforme: a pilot study.

@nl

P1433

Q43166491-774E7800-E1F8-4D21-B5F3-3AE71010BBC8

P1476

Q43166491-BCDE5D31-A1A6-43E3-A8E4-D1911F19DDDB

P2093

Q43166491-05C3AACD-34CA-40B3-9C3D-B6397F4BC3B6

Q43166491-0B53177D-F3E7-404D-A51C-AAB02692F8EF

Q43166491-1669AE80-7450-4E96-B8C9-7B44CC520B0F

Q43166491-BD5E78AA-668D-4BBF-946C-25947139023A

Q43166491-BEE9AC6C-699B-41AE-AC99-DD5C7D7DB69F

Q43166491-C5A0F688-644C-452B-B9AD-31886F47D794

Q43166491-D268C7AA-C83B-471A-B0E5-CEE27F5652A2

Q43166491-E48F0A8E-82AC-473E-B657-A591243D56BF

Q43166491-EA01FE44-2D6B-41BD-B998-913381C4D8BB

P2860

Q43166491-9E22D7CA-DC59-4297-AD06-C36001A90AC2

Q43166491-F548E03A-4AB8-41E0-9B57-83F3D19F6E32

P2888

Q43166491-04E52E7E-E4A3-4198-AB09-45FE7560A01E

P304

Q43166491-F64027A3-6011-4C85-A3AD-86A04A2FAF68

P31

Q43166491-EC6F08AE-A74E-46CA-9F3F-B2D0B14B8B92

P356

Q43166491-999DDCD8-BC21-41F8-B10A-766B83460A19

P433

Q43166491-423CA2DC-0092-4705-9807-44E662507A4F

P478

Q43166491-D2D36640-E0A3-424A-AA5A-B0C49DF2FA3A

P50

Q43166491-93847F85-2BF1-4F0C-B029-06870272354E

Q43166491-A32108A6-05C0-4405-959F-FD135B3B6E28

Q43166491-E6C1D79C-BF5B-42ED-9047-B371B842B31F

P577

Q43166491-23422B59-3F16-4904-BFF0-F7099D031738

P5875

Q43166491-89A3FB6A-26A6-431E-917F-CBC66D0FC548

P6179

Q43166491-BFAE54C2-3AE1-4EE8-AC75-41FCCAE72147

P698

Q43166491-51D45D2E-3AFD-46E6-8FE5-36738A1F3CBE

P921

Q43166491-4EE0C371-2694-4B3A-BD3C-18B92AAD3433

Q43166491-DFE2DAC9-93EB-4253-A87D-A11CFA16413C

P356

S11060-010-0131-Y

P1433

Journal of Neuro-Oncology

P1476

Integration of autologous dend ...... oma multiforme: a pilot study.

@en

P2093

Frank Van Calenbergh

http://www.w3.org/2001/XMLSchema#string

Guido Wilms

http://www.w3.org/2001/XMLSchema#string

Hilko Ardon

http://www.w3.org/2001/XMLSchema#string

Isabel Spencer Lopes

http://www.w3.org/2001/XMLSchema#string

Jan Goffin

http://www.w3.org/2001/XMLSchema#string

Patricia Bijttebier

http://www.w3.org/2001/XMLSchema#string

Philippe Demaerel

http://www.w3.org/2001/XMLSchema#string

Stefaan Van Gool

http://www.w3.org/2001/XMLSchema#string

Wim Maes

http://www.w3.org/2001/XMLSchema#string

P2860

Transient local response and persistent tumor control in a child with recurrent malignant glioma: treatment with combination therapy including dendritic cell therapy. Case report.

Thymic CD8+ T cell production strongly influences tumor antigen recognition and age-dependent glioma mortality.

P2888

s11060-010-0131-y

P304

261-272

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11060-010-0131-Y

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P50

Steven De Vleeschouwer

P577

2010-02-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41420472

http://www.w3.org/2001/XMLSchema#string

P6179

1035401258

http://www.w3.org/2001/XMLSchema#string

P698

20146084

http://www.w3.org/2001/XMLSchema#string

P921